Live feed
Filing
SC 13G
SC 13G0001493152-22-004807·3E Bioventures Capital, L.P.
Schedule 13G ownership disclosure
Cytek Biosciences Inc
Security class unavailable · CUSIP: 23285D109
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.2400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-22-004807
- Form type
- SC 13G
- Filer
- 3E Bioventures Capital, L.P.
- CIK
- CIK 1911673
- Filed
- Feb 17, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership